Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Plexpress Secures $2.3M to Commercialize TRAC High-Content Gene Expression Analysis Platform

Published: Thursday, April 19, 2012
Last Updated: Thursday, April 19, 2012
Bookmark and Share
Company targets applications including companion diagnostics and ADMET.

Plexpress has announced follow-on funding of up to $2.3M to commercialize its novel TRAC (Transcript Analysis with the aid of Affinity Capture) platform for high-content gene expression analysis.

The investment has been secured to commercialize the technology internationally, build up the ADMET screening service and develop TRAC specifically within the oncology sector.

Existing investors - Conor Technology Fund, VTT Ventures, Aloitusrahasto Vera and the Helsinki University Fund - as well as Tekes, the Finnish Funding Agency for Technology and Innovation, have invested $1.4M initially with further milestone payments of up to $900k.

As the potential applications and opportunities in genomic research continue to grow, the TRAC system is poised to provide the ideal method for the increased throughput and multiplex screening that the development of new therapies and diagnostics requires.

With TRAC, the expression of up to 30 genes can be routinely quantified in each plate well (30-plex), while thousands of samples can be processed quickly, easily and reproducibly.

The TRAC technology has been refined and validated over 10 years of development, initially at the Technical Research Centre of Finland, VTT, and subsequently at Plexpress, with over 50 separate projects completed successfully.

By avoiding the need for RNA extraction, cDNA conversion and amplification, the TRAC protocol takes only four hours to complete and RNA degradation is significantly reduced. This makes it fast, simple and cost-effective to implement, while lowering error rates and maximizing accuracy.

“This funding will enable Plexpress to pursue high value market opportunities, such as companion diagnostics and ADMET. TRAC provides significant benefits over existing technologies such as qPCR and microarrays, which do not offer either the throughput or the multiplexing that many genomics researchers require. Our early investors recognized these opportunities and have underlined their belief in TRAC with this continuing funding”, said Plexpress CEO, and leading expert in TRAC technology, Dr Jari Rautio.

Commenting on the renewed funding, MoB Managing Partner, Jari Mieskonen, of Conor Venture Partners said: “We are very happy that all current investors continued to support Plexpress in this follow-on investment round. The added involvement of Tekes gives us increased leverage for commercializing the TRAC technology and with the extremely positive feedback from key customers we foresee a fast market roll-out.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Genes That Increase Children's Risk Of Blood Infection Identified
A team led by Oxford University has identified genes that make certain children more susceptible to invasive bacterial infections by performing a large genome-wide association study in African children.
Poverty Marks a Gene, Predicting Depression
New study of high-risk teens reveals a biological pathway for depression.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Gene That Lowers Heart Attack Risk Identified
Individuals with a rare twelve-letter deletion from a gene on chromosome 17 have significantly reduced non-HDL cholesterol levels and a 35% lower than average risk of heart disease.
"Sunscreen" Gene May Guard Against Melanoma
USC-led study reveals that melanoma patients with deficient or mutant copies of the gene are less protected from harmful ultraviolet rays.
Myeloid-Derived Suppressor Cells Play Role in Tumor Growth
Researchers at Baylor College of Medicine have reported a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.
Transcription Factor Isoforms Implicated in Colon Diseases
UC Riverside study explains how distribution of two forms of a transcription factor in the colon influence risk of disease.
Roundup Impacts Gene Expression
Study published on the impact of low-dose toxicity of Roundup weed-killer on gene expression profiles.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!